Phase 2, Two-Stage Study of Avelumab and Axitinib in Patients with Mismatch Repair Proficient Recurrent or Persistent Endometrial Cancer.
Elizabeth K Lee, Niya Xiong,Carolyn Krasner,Madeline Polak, Susana Campos,Alexi A Wright,Joyce F Liu,Meghan Shea,Oladapo Yeku, Cesar Castro, Rebecca Porter,Elizabeth H Stover, Lani Koppermann, Josephine Smith,Hannah Sawyer, Martin Hayes, Ningxuan Zhou,Su-Chun Cheng, Sara Bouberhan,Kathleen L Pfaff,Scott J Rodig, Stephanie Jones,Richard T Penson,John Moroney,Gini F Fleming,Ursula A Matulonis,Panagiotis A Konstantinopoulos Gynecologic oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper